Skip to main content
. 2023 Jun 29;7:e2300030. doi: 10.1200/PO.23.00030

FIG 2.

FIG 2.

Influence of concurrent TP53, STK11, and KEAP1 mutations on OS to sotorasib. Kaplan-Meier curves of OS among patients with KRAS G12C-mutant Non–Small Cell lung cancer with or without concurrent mutations in (A) TP53, (B) STK11, and (C) KEAP1. Tick marks indicate censored data. **P < .01 for log-rank test between curves. OS, overall survival.